iifl-logo

Gland Pharma Ltd Historical Data

Add as a Preferred Source on Google
₹2,960.3
(4.09%)
Oct 27, 2026|03:57:04 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Gland Pharma Ltd Historical Data

27/09/2026calendar-icon
27/10/2026calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

28-Sep-2026

2,910

2,9282,884.22,89621,88364,84,96,811.21,56,998

29-Sep-2026

2,896.6

3,0242,896.62,989.765,7642,62,02,00,652.84,05,761

30-Sep-2026

2,990

3,007.72,8722,899.448,4571,55,52,15,750.72,40,163

01-Oct-2026

2,876

2,929.82,841.12,874.433,20594,20,67,783.11,87,759

05-Oct-2026

2,890

2,9202,863.12,911.538,82772,11,67,255.31,78,122

06-Oct-2026

2,921.1

3,019.82,898.13,006.154,7771,11,62,54,343.32,41,406

07-Oct-2026

3,026

3,1713,0193,150.689,0704,17,57,31,967.55,63,797

08-Oct-2026

3,162

3,170.53,049.53,079.147,5281,53,55,06,791.82,31,886

09-Oct-2026

3,059.1

3,121.93,008.23,061.822,02555,59,59,652.767,381

12-Oct-2026

3,070

3,095.93,0253,078.425,95364,91,06,907.61,14,669

13-Oct-2026

3,078.4

3,1053,0403,091.129,48363,83,52,152.81,29,542

14-Oct-2026

3,099

3,1053,0423,052.325,85254,66,54,581.11,00,902

15-Oct-2026

3,040.2

3,076.93,000.13,066.330,46047,61,08,343.583,899

16-Oct-2026

3,096.9

3,096.93,004.33,043.426,29950,02,06,470.679,328

19-Oct-2026

3,046.1

3,075.13,002.83,019.825,72550,77,71,107.592,823

21-Oct-2026

3,005.1

3,028.32,839.62,9351,48,5523,50,38,60,0817,30,701

22-Oct-2026

2,906.1

2,953.92,8292,850.444,61097,61,75,3421,87,517

23-Oct-2026

2,848.9

2,9242,769.82,826.866,6121,19,06,62,764.72,35,278

26-Oct-2026

2,815

2,867.82,788.42,843.943,7801,36,13,10,186.23,30,143

Gland Pharma: Related NEWS

Gland Pharma Stock Gains 7% as Q3 Revenue Climbs 22.5% to ₹1,695.3 Crore

The European business reported a 54 percent year on year surge in topline during the quarter.

29 Jan 2026|12:20 PM
Read More
Top Stocks for Today - 8th January 2026

Here are some of the stocks that may see significant price movement today: Infosys, Tata Steel, Cipla Limited, etc.

8 Jan 2026|07:31 AM
Read More
Top Stocks for Today - 4th November 2025

Here are some of the stocks that may see significant price movement: Bharti Airtel, Cipla, Gland Pharma, etc.

4 Nov 2025|08:01 AM
Read More
Top Stocks for Today - 14th July 2025

Here are some of the stocks that may see significant price movement today: Avenue Supermarts, BEML, Gland Pharma, etc.

14 Jul 2025|06:30 AM
Read More
Gland Pharma Gets USFDA Clearance for Visakhapatnam Facility

The receipt of the EIR marks the formal closure of the US health regulator’s pre-approval inspection, which was conducted between February 19 and February 25, 2025.

25 Jun 2025|12:07 PM
Read More
Top Stocks for Today - 5th June 2025

Here are some of the stocks that may see significant price movement today: Hindustan Aeronautics, Gland Pharma, REC, etc.

5 Jun 2025|07:53 AM
Read More
Gland Pharma gets USFDA approval for blood pressure drug

Gland Pharma also established that its version is bioequivalent and therapeutically equivalent to the reference listed drug.

4 Jun 2025|03:34 PM
Read More
Gland Pharma Q4 Net Profit Declines 3.1% to ₹186.5 Crore; Revenue Down 7.3% YoY

Gland Pharma net profit was at ₹186.5 crore as against ₹192.4 crore in the year-ago quarter of FY24.

22 May 2025|08:49 AM
Read More
Gland Pharma Gets USFDA Nod for Glaucoma Drug

Gland Pharma has secured exclusive rights as the first-to-file sponsor of this generic product. This makes it eligible for 180 days of marketing exclusivity in the US

30 Apr 2025|03:40 PM
Read More
USFDA Issues Three Observations to Gland Pharma's Visakhapatnam Facility

The FDA conducted the pre-approval inspection (PAI) from Feb. 19, 2025, to Feb. 25, 2025, as part of the regulatory process for sterile APIs.

26 Feb 2025|12:22 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.